Murali Ramachandra - Concepedia

Author

Murali Ramachandra

Aurigene Discovery Technologies (India)ORCID

Also Known As

M Ramachandra, M. Ramachandra, MURALIDHARA RAMACHANDRA, Murali Ramachandra, Muralidhara Ramachandra, Ramachandra, Murali

246

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Aurigene Discovery Technologies (India)National Institutes of Health National Cancer Institute Orion Corporation (Finland)University of Kansas Medical Center

About

Murali Ramachandra is an author at Aurigene Discovery Technologies (India) specializing in medicine, immunology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	34	2.4K
2	Biochemistry	12	13	1.5K
3	Natural Sciences	11	12	758
4	Biomolecular Engineering	4	4	192
5	Engineering	1	1	290

Murali Ramachandra

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
HIV-1 Protease Inhibitors Are Substrates for the<i>MDR</i>1 Multidrug Transporter Caroline Lee, Michael M. Gottesman, Carol Cardarelli, Biochemistry Protease InhibitorsBiochemistryMedicineHuman RetrovirusAntiviral Drug Development	1998	481
Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein Saibal Dey, Murali Ramachandra, Ira Pastan, Proceedings of the National Academy of Sciences Drug TargetGlycobiologyPharmacotherapyHuman P-glycoproteinChemical Biology	1997	336
Association between NS3 and NS5 Proteins of Dengue Virus Type 2 in the Putative RNA Replicase Is Linked to Differential Phosphorylation of NS5 Mini Kapoor, Luwen Zhang, Murali Ramachandra, Journal of Biological Chemistry	1995	317
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer Lanbo Xiao, Abhijit Parolia, Yuanyuan Qiao, Nature	2021	292
Characterization of an extracellular lignin peroxidase of the lignocellulolytic actinomycete Streptomyces viridosporus Murali Ramachandra, D. L. Crawford, Greg Hertel Applied and Environmental Microbiology BiosynthesisEngineeringBiochemistryBiocatalysisExtracellular Lignin Peroxidase	1988	290
Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition State Murali Ramachandra, Suresh V. Ambudkar, David Chen, Biochemistry	1998	253
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy Pottayil G. Sasikumar, Naremaddepalli S. Sudarshan, Srinivas Adurthi, Communications Biology	2021	144
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy Murali Ramachandra, Amena Rahman, Aihua Zou, Nature Biotechnology Synthetic VirologyImmunologyGene VectorOncolytic SpecificityRadiation Oncology	2001	132
Both ATP Sites of Human P-Glycoprotein Are Essential but Not Symmetric Christine A. Hrycyna, Murali Ramachandra, Ursula A. Germann, Biochemistry	1999	131
Extracellular Enzyme Activities during Lignocellulose Degradation by <i>Streptomyces</i> spp.: A Comparative Study of Wild-Type and Genetically Manipulated Strains Murali Ramachandra, Don L. Crawford, Anthony L. Pometto Applied and Environmental Microbiology	1987	122

Page 1